Squarepoint’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-69,002
| Closed | -$12.7M | – | 3049 |
|
|
2021
Q2 | $12.7M | Sell |
69,002
-25,223
| -27% | -$4.63M | 0.05% | 236 |
|
|
2021
Q1 | $14.4M | Buy |
94,225
+58,136
| +161% | +$8.89M | 0.08% | 182 |
|
|
2020
Q4 | $5.64M | Buy |
+36,089
| New | +$5.64M | 0.04% | 361 |
|
|
2020
Q3 | – | Sell |
-113,165
| Closed | -$12.7M | – | 2835 |
|
|
2020
Q2 | $12.7M | Buy |
113,165
+45,334
| +67% | +$5.09M | 0.21% | 121 |
|
|
2020
Q1 | $6.09M | Sell |
67,831
-34,239
| -34% | -$3.07M | 0.16% | 149 |
|
|
2019
Q4 | $11M | Sell |
102,070
-133,899
| -57% | -$14.5M | 0.07% | 260 |
|
|
2019
Q3 | $23.1M | Buy |
235,969
+178,839
| +313% | +$17.5M | 0.21% | 109 |
|
|
2019
Q2 | $7.48M | Buy |
+57,130
| New | +$7.48M | 0.07% | 317 |
|
|
2019
Q1 | – | Sell |
-69,327
| Closed | -$6.75M | – | 2484 |
|
|
2018
Q4 | $6.75M | Buy |
69,327
+15,824
| +30% | +$1.54M | 0.08% | 323 |
|
|
2018
Q3 | $7.44M | Buy |
53,503
+18,530
| +53% | +$2.58M | 0.09% | 299 |
|
|
2018
Q2 | $4.34M | Sell |
34,973
-66,674
| -66% | -$8.28M | 0.06% | 433 |
|
|
2018
Q1 | $11.3M | Buy |
+101,647
| New | +$11.3M | 0.18% | 150 |
|
|
2017
Q4 | – | Sell |
-102,262
| Closed | -$14.3M | – | 2412 |
|
|
2017
Q3 | $14.3M | Buy |
+102,262
| New | +$14.3M | 0.28% | 78 |
|
|
2017
Q2 | – | Sell |
-16,132
| Closed | -$1.96M | – | 1908 |
|
|
2017
Q1 | $1.96M | Buy |
+16,132
| New | +$1.96M | 0.05% | 386 |
|
|
2016
Q3 | – | Sell |
-16,574
| Closed | -$1.94M | – | 1357 |
|
|
2016
Q2 | $1.94M | Buy |
16,574
+14,199
| +598% | +$1.66M | 0.12% | 201 |
|
|
2016
Q1 | $331K | Buy |
+2,375
| New | +$331K | 0.03% | 789 |
|
|
2015
Q1 | – | Sell |
-3,100
| Closed | -$574K | – | 506 |
|
|
2014
Q4 | $574K | Buy |
+3,100
| New | +$574K | 0.56% | 59 |
|